IFPA Advocates for Psoriasis recognition at UN general Assembly Meetings
NEW YORK – The International Federation of Psoriasis Associations (IFPA) is leveraging this week’s United nations General Assembly (UNGA) meetings to push for greater inclusion of psoriasis within the global non-communicable disease (NCD) agenda. The organization argues that the experiences of the over 60 million people worldwide living with psoriasis must be central to health policy decisions.
On September 22nd, alongside UNGA, the IFPA is hosting a high-level conversation in partnership with Devex at the Devex NCD Pavilion in New York. Titled “Psoriasis Disease and NCDs: Place the Experience in the Center of Politics,” the event will feature IFPA Executive Director Frida Dunger and IFPA Ambassador Kate Reynolds, a psoriasis patient.
“People who live with psoriasis are more than just an illness,we are whole people,and we have to live our best life,just like everyone else,” said Reynolds. “I am traveling to New York to talk about psoriasis at this event, because in my opinion there should be no decisions about us without us.”
The IFPA,founded in 1971 and based in Stockholm,Sweden,represents national and regional patient associations globally. Dunger emphasized the necessity of integrated health policies, stating, “An integrative health policy is not optional, but essential to ensure that the over 60 million people who live worldwide are no longer left behind.”
The organization aims to utilize the UNGA platform to advocate for improved access to care and a more holistic approach to NCD prevention that recognizes the notable impact of psoriasis.
Further information and registration for the event are available at: https://pages.devex.com/devex-at-unga-80
More information about the IFPA can be found at: https://www.ifpa-pso.com/
